KYPROLIS should not be combined with melphalan and prednisone:Newly diagnosed transplant ineligible multiple myeloma patients have shown an increased risk of serious and fatal side effects when using KYPROLIS in combination with melphalan and prednisone. Possible fetal harm:KYPROLIS can cause harm to a ...
A type of white blood cell called a plasma cell makes antibodies that fight infections in your body. When you have multiple myeloma, these cells multiply the wrong way. They let too much protein (called immunoglobulin) into your bones and blood. It builds up throughout your body and damages...
Gabriel Hinojosa, PharmD, BCOP, looks beyond frontline regimens in multiple myeloma, and discusses treatment options, adverse events, and complexities in sequencing therapies.EP: 1.Pharmacists in Multiple Myeloma Care: Essential Roles and Patient Support EP: 2.Eligibility Factors in Multiple Myeloma ...
EP: 7.BCMA-Targeting Bispecific Agents for Relapsed/Refractory Multiple Myeloma Treatment EP: 8.CAR-T Therapies in Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 and KarMMA Studies EP: 9.Novel Agents Under Investigation for Multiple Myeloma ...
Learn more about REVLIMID®, a treatment option for multiple myeloma. See safety info and BOXED WARNINGS on fetal and hem tox & blood clots.
The multiple myeloma condition center is a comprehensive resource for clinical news and expert insights on multiple myeloma. Read more at OncLive.
Visit WebMD's Multiple Myeloma Health Center for in-depth, medically accurate, and physician reviewed health information about multiple myeloma including the symptoms, diagnosis, and treatment of the disease.
A method of treating multiple myeloma patients in stages characterized by an increase in the prevalence of (2) MM cells with the IL-6 non-responsive and / or (1) the CD45- phenotype, expression and comprising administering to a patient an amount of a compound of Ib. [Formula 1]...
“The diagnosis, workup, and treatment of myeloma have dramatically changed over the past 10 years. The therapeutic goal is to obtain deep remissions that translate into improved progression-free and overall survival. With combination therapy using immunomodulatory drugs, proteasome inhibitors, monoclonal...
The damage caused by multiple myeloma can lead to anemia, bone pain, frequent infections andkidney failure. "The treatment involves ... we call it plasma cell directed therapy," says Dr. Cook. "It's treatments that are specifically directed at theimmune system. So it's usually a combination...